OVERVIEW

The global market for CTMS is expected to hit USD 1,429.6 million by 2027, growing by 12.6% over the forecast period. Significant collaborations between Asian CROs and pharmaceutical companies, increased number of clinical trials in both developing and developed nations, availability of innovative and updated CTMS solutions, and increased government funding for clinical trials in Asian countries are key factors driving the growth of the CTMS market.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Clinical Trial Management System Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Clinical Trial Management System Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Clinical Trial Management System Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Clinical Trial Management System Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Clinical Trial Management System Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Clinical Trial Management System Market ? By Type (Market Size ? & million/billion)
  • 8.1 Enterprise CTMS
  • 8.2 Site CTMS

• 9 Global Clinical Trial Management System Market - By Delivery Mode
  • 9.1 Web-based (Hosted) CTMS
  • 9.2 Licensed Enterprise (On Premise) CTMS
  • 9.3 Cloud-based (SaaS) CTMS

• 10 Global Clinical Trial Management System Market - By Component
  • 10.1 Software
  • 10.2 Services

• 11 Global Clinical Trial Management System Market - By End-User
  • 11.1 Pharmaceutical and Biopharmaceutical Companies
  • 11.2 Contract Research Organizations
  • 11.3 Medical Device Companies
  • 11.4 Other

• 12 Global Clinical Trial Management System Market ? By Geography (Market Size ? &million/billion)
  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 U.K
    • 12.3.2 Germany
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia-Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 South Korea
    • 12.4.5 Rest of APAC
  • 12.5 Rest of the World
    • 12.5.1 South America
    • 12.5.2 Middle East
    • 12.5.3 Africa

• 13 Global Clinical Trial Management System Market ? Entropy
  • 13.1 New product launches
  • 13.2 M&A's, collaborations, JVs and partnerships

• 14 Global Clinical Trial Management System Market Company Profile (Key Players)
  • 14.1 Market Share, Company Revenue, Products, M&A, Developments
  • 14.2 Oracle
  • 14.3 Medidata Solutions
  • 14.4 Parexel
  • 14.5 Bio-Optronics
  • 14.6 Mastercontrol
  • 14.7 Forte Research Systems
  • 14.8 IBM
  • 14.9 Bioclinica
  • 14.10 Datatrak
  • 14.11 Veeva Systems
  • 14.12 Company 11 & more

• 15 Global Clinical Trial Management System Market - Appendix
  • 15.1 Sources
  • 15.2 Abbreviations